training with all mpMRI slices encompassing lesion volumes or single mpMRI slice containing largest diameter of each lesion. Data were partitioned to 80% training and 20% validation. Outcome was measured as percent correct classification on the validation dataset.
INTRODUCTION AND OBJECTIVES: Multiparametric magnetic resonance imaging (mpMRI) has revolutionized the diagnosis of prostate cancer. However, there is a group of prostate cancer patients for whom mpMRI has not been able to demonstrate a cancerous lesion. We sought to analyze the transcriptomic and histologic differences visible and non-visible mpMRI lesions.
METHODS: From a single surgeon series, we have performed a retrospective analysis on 283 patients who underwent radical prostatectomy (RP). All patients had preoperative mpMRI and postoperative genomic classifier (GC) test performed. We identified the location of the tissue block submitted for GC score analysis and retrospectively analyzed whether cancer tissue corresponded to an mpMRI lesion or not. PI-RADS v2 was used for characterizing lesions. Microarray based gene expression analysis was performed to gather RNA expression data. Weighted gene correlation network analysis (WGCNA) was applied to identify transcriptomic signatures associated with mpMRI visibility.
RESULTS: Tumors were visible in 195 (68.9%) of patients. Among baseline cahracteristics, there were no significant differences with regards to age (p[0. WGCNA identified networks of correlated genes related to mpMRI visibility. After adjusting for PSA, race, pT stage, and Gleason score, WGCNA revealed 1 gene network (424 genes) whose eigengene was significantly downregulated in patients with mpMRI visible tumors (p [ 0.077). These downregulated genes showed significant enrichment (FDR < 0.01) of genes related to extracellular matrix organization, antibody-mediated complement activation, smooth muscle contraction, and integrin signaling. Using a previously published gene signature, we also found that mpMRI-visible tumors displayed greater expression of an androgen receptor signaling gene signature compared to mpMRI-invisible tumors.
CONCLUSIONS: Network based transcriptomic analysis revealed a 424 gene network enriched for genes related to extracellular matrix organization and complement activation that offers a novel insight into molecular mechanisms of mpMRI visibility in prostate cancer.
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MP74-12 PATIENT SELECTION FOR PROSTATE BIOPSY USING A MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MPMRI) BASED TRIAGE PATHWAY: FEASIBILITY, PERFORMANCE IN AN ACADEMIC, TERTIARY CENTER
Matthew Roberts*, Peter Donato, Andrew Morton, Geoff Coughlin, Rachel Esler, Nigel Dunglison, Robert Gardiner, John Yaxley, Brisbane, Australia INTRODUCTION AND OBJECTIVES: Multiparametric magnetic resonance imaging (mpMRI) of the prostate has been shown to improve prostate cancer detection by facilitating targeted biopsy and reducing negative biopsies due to high sensitivity. Reports on the feasibility of implementing a mpMRI-based triage system to guide patient selection for biopsy are limited, hence this study sought to describe the experience of the mpMRI-based triage pathway introduced in an academic, tertiary centre, including cancer diagnostic performance and avoiding unnecessary biopsies.
METHODS: An observational retrospective cohort study of consecutive patients attending an academic, tertiary center between June 2014 and July 2017 who underwent mpMRI for investigation of prostate cancer were considered. Standard clinical, MRI-related and histopathological parameters were collected for analysis of biopsyavoidance and diagnostic accuracy of biopsy approach. Vol. 201, No. 4S, Supplement, Monday, May 6, 2019 THE JOURNAL OF UROLOGY Ò e1077
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